tofacitinib citrate

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 540737-29-9

Where It Comes From

27 FDA-registered drug labelers
Alivus Life Sciences Limited
Almon Healthcare Private Limited
Aurore Pharmaceuticals Private Limited
AX Pharmaceutical Corp
Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
DARMERICA, LLC
DELMAR CHEMICALS INC
Dr. Reddy's Laboratories Limited
Honour Lab Limited
Hunan Jiudian Pharmaceutical Co.,Ltd.
Lee Pharma Limited
Matrix Pharmacorp Private Limited
Metrochem API Private Limited
Micro Labs Limited
MSN Laboratories Private Limited
Nantong Chanyoo Pharmatech Co., Ltd
Olon S.p.A.
Pfizer Asia Manufacturing Pte Ltd
Pfizer Ireland Pharmaceuticals Unlimited Company
Pfizer Laboratories Div Pfizer Inc
Qingdao Biopeptek Co., Ltd.
SUN PHARMACEUTICAL INDUSTRIES, INC.
U.S. Pharmaceuticals
Unichem Laboratories Limited, India
Zhejiang Ausun Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Zydus Lifesciences Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • Xeljanz XR
  • Xeljanz
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS540737-29-9
PubChem CID10174505
DTXSIDDTXSID80202404
FormulaC22H28N6O8
Mol. Weight504.5 g/mol
SMILESCC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

Data Sources

101745052026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tofacitinib citrate/cids/JSON

Archive: data/sources/pubchem_name/tofacitinib citrate.json

CAS 540737-29-92026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json